| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Laboratory Medicine and Pathology [G. P. S., K. B. R., A. K. B.] and Radiology [H. Z. H.], University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey 07103
S-phase-active cytotoxic drugs selectively damage leukemic cells, but the mechanisms of this action are not clear. We have investigated the previously reported potentiation of toxicity of 1-ß-D-arabinofuranosylcytosine (ara-C) to HL-60 cells by the differentiation-inducing steroid, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], and compared the results with the effects of other drugs which inhibit DNA synthesis. Determination of the intracellular content of the active metabolite of ara-C, ara-CTP, excluded more prolonged retention of the drug as the basis for potentiation of cytotoxicity. Alkaline elution of replicating DNA showed that 1,25(OH)2D3 added with or immediately after ara-C or hydroxyurea reduced the rate maturation of the replicating DNA and resulted in an increased proportion of smaller DNA fragments. However, pretreatment of the cells with 1,25(OH)2D3 inhibited this effect of the drugs on replication of DNA. No direct effect of 1,25(OH)2D3 on replicating DNA could be detected. The results suggest that the early events which initiate cell differentiation may protect an intact DNA replicative machinery from S-phase-active drugs but reduce the rate of DNA maturation once DNA integrity has been compromised by inhibitors of DNA synthesis.
1 Supported by Grant RO1 CA44722 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at Department of Laboratory Medicine and Pathology, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103.
Received 12/10/90. Accepted 4/19/91.
This article has been cited by other articles:
![]() |
Y. Ji, H. J. Lee, C. Goodman, M. Uskokovic, K. Liby, M. Sporn, and N. Suh The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1452 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Itagaki, K. B. Kannan, and C. J. Hauser Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils J. Leukoc. Biol., February 1, 2005; 77(2): 181 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, Q. Wang, X. Wang, and G. P. Studzinski Up-Regulation of Egr1 by 1,25-Dihydroxyvitamin D3 Contributes to Increased Expression of p35 Activator of Cyclin-Dependent Kinase 5 and Consequent Onset of the Terminal Phase of HL60 Cell Differentiation Cancer Res., August 1, 2004; 64(15): 5425 - 5433. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji and G. P. Studzinski Retinoblastoma Protein and CCAAT/Enhancer-Binding Protein {beta} Are Required for 1,25-Dihydroxyvitamin D3-Induced Monocytic Differentiation of HL60 Cells Cancer Res., January 1, 2004; 64(1): 370 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Itagaki and C. J. Hauser Sphingosine 1-Phosphate, a Diffusible Calcium Influx Factor Mediating Store-operated Calcium Entry J. Biol. Chem., July 18, 2003; 278(30): 27540 - 27547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium Cancer Res., March 15, 2003; 63(6): 1325 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Danilenko, X. Wang, and G. P. Studzinski Carnosic Acid and Promotion of Monocytic Differentiation of HL60-G Cells Initiated by Other Agents J Natl Cancer Inst, August 15, 2001; 93(16): 1224 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen and G. P. Studzinski Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation Blood, June 15, 2001; 97(12): 3763 - 3767. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |